skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 374  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: Database: SWEPUB Freely available online remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
Material Type:
Article
Add to My Research

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Annals of oncology, 2017-07, Vol.28 (7), p.1631-1639 [Peer Reviewed Journal]

2017 THE AUTHORS ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2017 ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx176 ;PMID: 28475671

Full text available

2
Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen
Material Type:
Article
Add to My Research

Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen

Nature immunology, 2013-11, Vol.14 (11), p.1173-1182 [Peer Reviewed Journal]

Copyright Nature Publishing Group Nov 2013 ;2013 Nature America, Inc. All rights reserved 2013 ;ISSN: 1529-2908 ;ISSN: 1529-2916 ;EISSN: 1529-2916 ;DOI: 10.1038/ni.2714 ;PMID: 24076634

Full text available

3
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Material Type:
Article
Add to My Research

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Nature communications, 2017-11, Vol.8 (1), p.1738-1738, Article 1738 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2017 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-017-01460-0 ;PMID: 29170503

Full text available

4
Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome
Material Type:
Article
Add to My Research

Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome

Clinical cancer research, 2010-07, Vol.16 (13), p.3356-3367 [Peer Reviewed Journal]

ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-09-2509 ;PMID: 20460471

Full text available

5
WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells
Material Type:
Article
Add to My Research

WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells

Molecular cancer, 2014-04, Vol.13 (1), p.88-88, Article 88 [Peer Reviewed Journal]

COPYRIGHT 2014 BioMed Central Ltd. ;2014 Ekström et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. ;Copyright © 2014 Ekström et al.; licensee BioMed Central Ltd. 2014 Ekström et al.; licensee BioMed Central Ltd. ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/1476-4598-13-88 ;PMID: 24766647

Full text available

6
Basal cell carcinoma - molecular biology and potential new therapies
Material Type:
Article
Add to My Research

Basal cell carcinoma - molecular biology and potential new therapies

The Journal of clinical investigation, 2012-02, Vol.122 (2), p.455-463 [Peer Reviewed Journal]

Copyright American Society for Clinical Investigation Feb 2012 ;Copyright © 2012, American Society for Clinical Investigation 2012 ;ISSN: 0021-9738 ;ISSN: 1558-8238 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI58779 ;PMID: 22293184

Full text available

7
Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes
Material Type:
Article
Add to My Research

Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes

International journal of cancer, 2020-03, Vol.146 (6), p.1652 [Peer Reviewed Journal]

ISSN: 1097-0215 ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.32503

Digital Resources/Online E-Resources

8
Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors
Material Type:
Article
Add to My Research

Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors

JAMA dermatology (Chicago, Ill.), 2016-08, Vol.152 (8), p.889 [Peer Reviewed Journal]

ISSN: 2168-6084 ;EISSN: 2168-6084 ;DOI: 10.1001/jamadermatol.2016.0939

Digital Resources/Online E-Resources

9
BRN2 is a non-canonical melanoma tumor-suppressor
Material Type:
Article
Add to My Research

BRN2 is a non-canonical melanoma tumor-suppressor

Nature communications, 2021-06, Vol.12 (1), p.3707-16, Article 3707 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-23973-5 ;PMID: 34140478

Full text available

10
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Material Type:
Article
Add to My Research

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

Journal of translational medicine, 2011-11, Vol.9 (1), p.204-204, Article 204 [Peer Reviewed Journal]

COPYRIGHT 2011 BioMed Central Ltd. ;2011 Hamid et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;info:eu-repo/semantics/openAccess ;Copyright ©2011 Hamid et al; licensee BioMed Central Ltd. 2011 Hamid et al; licensee BioMed Central Ltd. ;ISSN: 1479-5876 ;EISSN: 1479-5876 ;DOI: 10.1186/1479-5876-9-204 ;PMID: 22123319

Full text available

11
MicroRNA-125b Down-regulates Matrix Metallopeptidase 13 and Inhibits Cutaneous Squamous Cell Carcinoma Cell Proliferation, Migration, and Invasion
Material Type:
Article
Add to My Research

MicroRNA-125b Down-regulates Matrix Metallopeptidase 13 and Inhibits Cutaneous Squamous Cell Carcinoma Cell Proliferation, Migration, and Invasion

The Journal of biological chemistry, 2012-08, Vol.287 (35), p.29899-29908 [Peer Reviewed Journal]

2012 © 2012 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. ;2012 by The American Society for Biochemistry and Molecular Biology, Inc. 2012 ;ISSN: 0021-9258 ;ISSN: 1083-351X ;EISSN: 1083-351X ;DOI: 10.1074/jbc.M112.391243 ;PMID: 22782903

Full text available

12
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
Material Type:
Article
Add to My Research

Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma

Molecular oncology, 2020-05, Vol.14 (5), p.933-950 [Peer Reviewed Journal]

2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1574-7891 ;EISSN: 1878-0261 ;DOI: 10.1002/1878-0261.12663 ;PMID: 32147909

Full text available

13
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma
Material Type:
Article
Add to My Research

Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003198 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 2051-1426 ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2021-003198 ;PMID: 35074902

Full text available

14
Association of phenotypic characteristics and UV radiation exposure with risk of melanoma on different body sites
Material Type:
Article
Add to My Research

Association of phenotypic characteristics and UV radiation exposure with risk of melanoma on different body sites

JAMA dermatology (Chicago, Ill.), 2019-01, Vol.155 (1), p.39 [Peer Reviewed Journal]

info:eu-repo/semantics/openAccess ;ISSN: 2168-6084 ;ISSN: 2168-6068 ;EISSN: 2168-6084 ;DOI: 10.1001/jamadermatol.2018.3964

Digital Resources/Online E-Resources

15
Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy
Material Type:
Article
Add to My Research

Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy

Oncotarget, 2015-05, Vol.6 (14), p.12297-12309

Copyright: © 2015 Cirenajwis et al. 2015 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.3655 ;PMID: 25909218

Full text available

16
Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis
Material Type:
Article
Add to My Research

Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis

Journal of investigative dermatology, 2018-04, Vol.138 (4), p.882-892 [Peer Reviewed Journal]

2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 0022-202X ;ISSN: 1523-1747 ;EISSN: 1523-1747 ;DOI: 10.1016/j.jid.2017.09.049 ;PMID: 29104160

Full text available

17
Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC)
Material Type:
Article
Add to My Research

Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC)

International journal of cancer, 2023-02, Vol.152 (3), p.348-362 [Peer Reviewed Journal]

info:eu-repo/semantics/openAccess ;Attribution ;ISSN: 0020-7136 ;ISSN: 1097-0215 ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.34253 ;PMID: 36053839

Digital Resources/Online E-Resources

18
Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma
Material Type:
Article
Add to My Research

Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma

Scientific reports, 2019-08, Vol.9 (1), p.12150-11, Article 12150 [Peer Reviewed Journal]

2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-019-48635-x ;PMID: 31434983

Full text available

19
Challenges in assessing the sunscreen-melanoma association
Material Type:
Article
Add to My Research

Challenges in assessing the sunscreen-melanoma association

International journal of cancer, 2019-06, Vol.144 (11), p.2651 [Peer Reviewed Journal]

info:eu-repo/semantics/openAccess ;ISSN: 0020-7136 ;ISSN: 1097-0215 ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.31997

Digital Resources/Online E-Resources

20
MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant Melanoma
Material Type:
Article
Add to My Research

MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant Melanoma

Journal of investigative dermatology, 2010-08, Vol.130 (8), p.2062-2070 [Peer Reviewed Journal]

2010 The Society for Investigative Dermatology, Inc ;2015 INIST-CNRS ;Copyright Nature Publishing Group Aug 2010 ;ISSN: 0022-202X ;ISSN: 1523-1747 ;EISSN: 1523-1747 ;DOI: 10.1038/jid.2010.63 ;PMID: 20357817 ;CODEN: JIDEAE

Full text available

Results 1 - 20 of 374  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (344)

Refine My Results

Creation Date 

From To
  1. Before 2000  (17)
  2. 2000 To 2005  (58)
  3. 2006 To 2011  (67)
  4. 2012 To 2018  (121)
  5. After 2018  (112)
  6. More options open sub menu

Resource Type 

  1. Articles  (352)
  2. Thesises (postgraduate)  (22)
  3. More options open sub menu

Language 

  1. English  (373)
  2. Japanese  (39)
  3. Swedish  (1)
  4. Norwegian  (1)
  5. More options open sub menu

Searching Remote Databases, Please Wait